Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Rodondi

Showing results (21-30 of 531) with videos related to

Pageof 54
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 2, 2013
Subclinical hypothyroidism and cardiovascular risk: how to end the controversyNicolas Rodondi, Douglas C Bauer
The American Journal of Medicine|October 7, 2004
Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular eventsNicolas Rodondi, Douglas C Bauer
BMJ (Clinical Research Ed.)|February 18, 2009
HDL cholesterol and cardiovascular riskWilliam A Ghali, Nicolas Rodondi
Revue Medicale Suisse|March 1, 2018
[2018 new recommendations for dyslipidemia : a critical review of evidence]Carole E Aubert, Nicolas Rodondi
Revue Medicale Suisse|March 6, 2020
[New European and American guidelines on the management of blood cholesterol : similarities and differences]Audrey Butty, Nicolas Rodondi, David Nanchen
Revue Medicale Suisse|June 16, 2015
[Working together is a success]Gérard Waeber, Bertrand Kiefer, Nicolas Rodondi
Revue Medicale Suisse|April 5, 2012
[Lipid-lowering treatment and liver dysfunction]Baris Gencer, Darius Moradpour, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[PCSK9 inhibitors: new treatment to lower cholesterol]Baris Gencer, Nicolas Rodondi, François Mach
The New England Journal of Medicine|August 29, 2009
Residents' work hoursReto Auer, Drahomir Aujesky, Nicolas Rodondi
Journal of General Internal Medicine|May 26, 2026
Evidence in All Policies: Restoring Science to Public Health and Clinical Decision-MakingArnaud Chiolero, Nicolas Rodondi, Valérie Santschi
Pageof 54

Showing results (21-30 of 531) with videos related to

Sort By:
Pageof 54
The Journal of Clinical Endocrinology and Metabolism|May 2, 2013
Subclinical hypothyroidism and cardiovascular risk: how to end the controversyNicolas Rodondi, Douglas C Bauer
The American Journal of Medicine|October 7, 2004
Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular eventsNicolas Rodondi, Douglas C Bauer
BMJ (Clinical Research Ed.)|February 18, 2009
HDL cholesterol and cardiovascular riskWilliam A Ghali, Nicolas Rodondi
Revue Medicale Suisse|March 1, 2018
[2018 new recommendations for dyslipidemia : a critical review of evidence]Carole E Aubert, Nicolas Rodondi
Revue Medicale Suisse|March 6, 2020
[New European and American guidelines on the management of blood cholesterol : similarities and differences]Audrey Butty, Nicolas Rodondi, David Nanchen
Revue Medicale Suisse|June 16, 2015
[Working together is a success]Gérard Waeber, Bertrand Kiefer, Nicolas Rodondi
Revue Medicale Suisse|April 5, 2012
[Lipid-lowering treatment and liver dysfunction]Baris Gencer, Darius Moradpour, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[PCSK9 inhibitors: new treatment to lower cholesterol]Baris Gencer, Nicolas Rodondi, François Mach
The New England Journal of Medicine|August 29, 2009
Residents' work hoursReto Auer, Drahomir Aujesky, Nicolas Rodondi
Journal of General Internal Medicine|May 26, 2026
Evidence in All Policies: Restoring Science to Public Health and Clinical Decision-MakingArnaud Chiolero, Nicolas Rodondi, Valérie Santschi
Pageof 54